These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31767724)
1. Linker Editing of Pneumococcal Lysin ClyJ Conveys Improved Bactericidal Activity. Yang H; Luo D; Etobayeva I; Li X; Gong Y; Wang S; Li Q; Xu P; Yin W; He J; Nelson DC; Wei H Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767724 [No Abstract] [Full Text] [Related]
2. A Choline-Recognizing Monomeric Lysin, ClyJ-3m, Shows Elevated Activity against Streptococcus pneumoniae. Luo D; Huang L; Gondil VS; Zhou W; Yang W; Jia M; Hu S; He J; Yang H; Wei H Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958710 [No Abstract] [Full Text] [Related]
3. ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain. Yang H; Gong Y; Zhang H; Etobayeva I; Miernikiewicz P; Luo D; Li X; Zhang X; Dąbrowska K; Nelson DC; He J; Wei H Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30642930 [No Abstract] [Full Text] [Related]
4. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae. Díez-Martínez R; De Paz HD; García-Fernández E; Bustamante N; Euler CW; Fischetti VA; Menendez M; García P J Antimicrob Chemother; 2015; 70(6):1763-73. PubMed ID: 25733585 [TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of a chimeric lysin ClyV with improved bactericidal activity against Streptococcus agalactiae in vitro and in vivo. Huang L; Luo D; Gondil VS; Gong Y; Jia M; Yan D; He J; Hu S; Yang H; Wei H Appl Microbiol Biotechnol; 2020 Feb; 104(4):1609-1619. PubMed ID: 31900556 [TBL] [Abstract][Full Text] [Related]
6. Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia. Vouillamoz J; Entenza JM; Giddey M; Fischetti VA; Moreillon P; Resch G Int J Antimicrob Agents; 2013 Nov; 42(5):416-21. PubMed ID: 23992647 [TBL] [Abstract][Full Text] [Related]
7. Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module. Díez-Martínez R; de Paz HD; Bustamante N; García E; Menéndez M; García P Antimicrob Agents Chemother; 2013 Nov; 57(11):5355-65. PubMed ID: 23959317 [TBL] [Abstract][Full Text] [Related]
8. PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related Species. Blázquez B; Fresco-Taboada A; Iglesias-Bexiga M; Menéndez M; García P Front Microbiol; 2016; 7():1156. PubMed ID: 27516758 [TBL] [Abstract][Full Text] [Related]
9. Export of the pneumococcal phage SV1 lysin requires choline-containing teichoic acids and is holin-independent. Frias MJ; Melo-Cristino J; Ramirez M Mol Microbiol; 2013 Jan; 87(2):430-45. PubMed ID: 23171061 [TBL] [Abstract][Full Text] [Related]
10. A Highly Active Chimeric Lysin with a Calcium-Enhanced Bactericidal Activity against Li X; Wang S; Nyaruaba R; Liu H; Yang H; Wei H Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33921682 [TBL] [Abstract][Full Text] [Related]
11. Interrogation of the contribution of (endo)lysin domains to tune their bacteriolytic efficiency provides a novel clue to design superior antibacterials. Gallego-Páramo C; Hernández-Ortiz N; García P; Menéndez M Int J Biol Macromol; 2022 Dec; 223(Pt A):1042-1053. PubMed ID: 36370862 [TBL] [Abstract][Full Text] [Related]
12. The pneumococcal cell wall degrading enzymes: a modular design to create new lysins? López R; García E; García P; García JL Microb Drug Resist; 1997; 3(2):199-211. PubMed ID: 9185148 [TBL] [Abstract][Full Text] [Related]
13. A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia. Lood R; Raz A; Molina H; Euler CW; Fischetti VA Antimicrob Agents Chemother; 2014 Jun; 58(6):3073-84. PubMed ID: 24637688 [TBL] [Abstract][Full Text] [Related]
14. SP-CHAP, an endolysin with enhanced activity against biofilm pneumococci and nasopharyngeal colonization. Alreja AB; Appel AE; Zhu JC; Riley SP; Gonzalez-Juarbe N; Nelson DC mBio; 2024 Apr; 15(4):e0006924. PubMed ID: 38470268 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1. Hermoso JA; Monterroso B; Albert A; Galán B; Ahrazem O; García P; Martínez-Ripoll M; García JL; Menéndez M Structure; 2003 Oct; 11(10):1239-49. PubMed ID: 14527392 [TBL] [Abstract][Full Text] [Related]
16. Structural and thermodynamic characterization of Pal, a phage natural chimeric lysin active against pneumococci. Varea J; Monterroso B; Sáiz JL; López-Zumel C; García JL; Laynez J; García P; Menéndez M J Biol Chem; 2004 Oct; 279(42):43697-707. PubMed ID: 15247237 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling. Sheehan MM; García JL; López R; García P FEMS Microbiol Lett; 1996 Jun; 140(1):23-8. PubMed ID: 8666197 [TBL] [Abstract][Full Text] [Related]
18. The lytic enzyme of the pneumococcal phage Dp-1: a chimeric lysin of intergeneric origin. Sheehan MM; García JL; López R; García P Mol Microbiol; 1997 Aug; 25(4):717-25. PubMed ID: 9379901 [TBL] [Abstract][Full Text] [Related]
19. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Loeffler JM; Djurkovic S; Fischetti VA Infect Immun; 2003 Nov; 71(11):6199-204. PubMed ID: 14573637 [TBL] [Abstract][Full Text] [Related]
20. PlyC: a multimeric bacteriophage lysin. Nelson D; Schuch R; Chahales P; Zhu S; Fischetti VA Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10765-70. PubMed ID: 16818874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]